Showing 1 - 10 of 12
Markets for pharmaceuticals belong to the most intensly regulated markets. Manufacturers of pharmaceutical products frequently argue that regulatory interventions impede innovative activities. In this paper we scrutinize two important changes of the regulatory framework of the market for...
Persistent link: https://www.econbiz.de/10005677741
Persistent link: https://www.econbiz.de/10007476897
Persistent link: https://www.econbiz.de/10007477199
Persistent link: https://www.econbiz.de/10007479679
Persistent link: https://www.econbiz.de/10007522340
Persistent link: https://www.econbiz.de/10007737017
Persistent link: https://www.econbiz.de/10007450189
The paper gives a brief overview of probable further developments of the EU-ETS. At first, we discuss scenarios for the auspices of the Post-Kyoto-Regime providing a general framework of the EU-ETS in the period after 2012. We find that Europe is likely to still have an ambitious CO2-regime...
Persistent link: https://www.econbiz.de/10005071452
Persistent link: https://www.econbiz.de/10005607011
Although Russia's WTO-accession is foreseeable, there are still deficits in the literature on its concrete effects on the sectoral and regional levels. In this paper we analyze effects on Russia's chemical and petrochemical sectors (CPS), which are, unlike for example its oil and mineral gas...
Persistent link: https://www.econbiz.de/10009195306